Published on in Vol 2 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/45000, first published
.
Artificial Intelligence–Enabled Software Prototype to Inform Opioid Pharmacovigilance From Electronic Health Records: Development and Usability Study
Artificial Intelligence–Enabled Software Prototype to Inform Opioid Pharmacovigilance From Electronic Health Records: Development and Usability Study
Journals
- Bhattarai K, Oh I, Sierra J, Tang J, Payne P, Abrams Z, Lai A. Leveraging GPT-4 for identifying cancer phenotypes in electronic health records: a performance comparison between GPT-4, GPT-3.5-turbo, Flan-T5, Llama-3-8B, and spaCy’s rule-based and machine learning-based methods. JAMIA Open 2024;7(3) View
- Zhang X, Tsang C, Ford D, Wang J. Student Pharmacists’ Perceptions of Artificial Intelligence and Machine Learning in Pharmacy Practice and Pharmacy Education. American Journal of Pharmaceutical Education 2024:101309 View
- Golder S, Xu D, O’Connor K, Wang Y, Batra M, Hernandez G. Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review. Drug Safety 2025;48(4):321 View
- Gomase V. Pharmacovigilance - Technological Advancements, Recent Developments and Innovations. Current Drug Safety 2025;20(4):423 View